6 completed, 1 active not recruiting, 1 unknown. 8 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Active not recruiting 1, Unknown 1 |
Follow edoxaban: new trials by email Literature Review of edoxaban trials Research Report on edoxaban
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban Edoxaban 60 MG [Lixiana], Edoxaban 60 MG [Lixiana] + Grapefruit Juice - Healthy | Phase 1 | Active not recruiting | Hyewon Chung | 14 | 2025-09-02 | 2025-09-16 |
| Single Dose Trial of VMX-C001 in Healthy Subjects With and Without FXa Direct Oral Anticoagulant VMX-C001, Placebo, Rivaroxaban 20 mg Oral Tablet - Coagulation Disorder | Phase 1 | Completed | VarmX B.V. | 40 | 2024-02-21 | 2026-09-09 |
| PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg - Healthy | Phase 1 | Completed | HK inno.N Corporation | 87 | 2023-03-06 | 2023-12-11 |
| Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab - Anticoagulant Therapy | Phase 1 | Unknown | Doasense GmbH | 24 | 2022-07-01 | 2022-08-08 |
| Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects VMX-C001, Placebo, Apixaban - Coagulation Disorder | Phase 1 | Completed | VarmX B.V. | 105 | 2021-10-29 | 2023-06-02 |
| A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa Andexanet alfa (Gen 1 Process 2), Apixaban 5 MG, Rivaroxaban 20 MG - Bleeding | Phase 1 | Completed | Portola Pharmaceuticals | 153 | 2017-02-26 | 2023-08-08 |
| Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study Edoxaban low dose, Edoxaban high dose - Deep Vein Thrombosis, Venous Thromboembolism | Phase 1 | Completed | Daiichi Sankyo | 66 | 2014-11-05 | 2023-10-11 |
| A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation 60mg edoxaban, 180mg edoxaban, 50 IU/kg Beriplex P/N - Bleeding | Phase 1 | Completed | Daiichi Sankyo | 110 | 2013-10-01 | 2019-02-12 |
Hemorrhage (2) · Hemostatic Disorders (2) · Thrombosis (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Daiichi Sankyo (2) · VarmX B.V. (2) · Doasense GmbH (1) · HK inno.N Corporation (1) · Hyewon Chung (1) · Portola Pharmaceuticals (1)
United States (3) · Netherlands (2) · South Korea (2) · Canada (1) · France (1) · Germany (1) · India (1) · Italy (1) · Lebanon (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Armin Schultz, MD (1) · Min-Gul Kim (1)
2015 (1), 2023 (1)